201 related articles for article (PubMed ID: 37695856)
1. The microbial-derived bile acid lithocholate and its epimers inhibit
Kisthardt SC; Thanissery R; Pike CM; Foley MH; Theriot CM
J Bacteriol; 2023 Sep; 205(9):e0018023. PubMed ID: 37695856
[No Abstract] [Full Text] [Related]
2. The microbial derived bile acid lithocholate and its epimers inhibit
Kisthardt SC; Thanissery R; Pike CM; Foley MH; Theriot CM
bioRxiv; 2023 Jun; ():. PubMed ID: 37333390
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids.
Thanissery R; Winston JA; Theriot CM
Anaerobe; 2017 Jun; 45():86-100. PubMed ID: 28279860
[TBL] [Abstract][Full Text] [Related]
4. Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis.
Pike CM; Tam J; Melnyk RA; Theriot CM
Infect Immun; 2022 Aug; 90(8):e0015322. PubMed ID: 35862710
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine.
Theriot CM; Bowman AA; Young VB
mSphere; 2016; 1(1):. PubMed ID: 27239562
[TBL] [Abstract][Full Text] [Related]
6. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
[TBL] [Abstract][Full Text] [Related]
7. Strain-Dependent Inhibition of Clostridioides difficile by Commensal
Reed AD; Nethery MA; Stewart A; Barrangou R; Theriot CM
J Bacteriol; 2020 May; 202(11):. PubMed ID: 32179626
[No Abstract] [Full Text] [Related]
8. Gut associated metabolites and their roles in
Aguirre AM; Sorg JA
Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
[No Abstract] [Full Text] [Related]
10. Identification of a Bile Acid-Binding Transcription Factor in
Forster ER; Yang X; Tai AK; Hang HC; Shen A
ACS Chem Biol; 2022 Nov; 17(11):3086-3099. PubMed ID: 36279369
[No Abstract] [Full Text] [Related]
11. The microbial metabolite urolithin A reduces
Ghosh S; Erickson D; Chua MJ; Collins J; Jala VR
mSystems; 2024 Feb; 9(2):e0125523. PubMed ID: 38193707
[No Abstract] [Full Text] [Related]
12. The role of the gut microbiome in colonization resistance and recurrent
Seekatz AM; Safdar N; Khanna S
Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405
[TBL] [Abstract][Full Text] [Related]
13. Review and Commentary on the Importance of Bile Acids in the Life Cycle of Clostridioides difficile in Children and Adults.
Faden H
J Pediatric Infect Dis Soc; 2021 May; 10(5):659-664. PubMed ID: 33626138
[TBL] [Abstract][Full Text] [Related]
14. Clostridioides difficile infection induces a rapid influx of bile acids into the gut during colonization of the host.
Wexler AG; Guiberson ER; Beavers WN; Shupe JA; Washington MK; Lacy DB; Caprioli RM; Spraggins JM; Skaar EP
Cell Rep; 2021 Sep; 36(10):109683. PubMed ID: 34496241
[TBL] [Abstract][Full Text] [Related]
15. Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.
Wang S; Heuler J; Wickramage I; Sun X
Microbiol Spectr; 2022 Apr; 10(2):e0178821. PubMed ID: 35315695
[TBL] [Abstract][Full Text] [Related]
16. Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.
Winston JA; Theriot CM
Anaerobe; 2016 Oct; 41():44-50. PubMed ID: 27163871
[TBL] [Abstract][Full Text] [Related]
17. An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains.
Phan JR; Do DM; Truong MC; Ngo C; Phan JH; Sharma SK; Schilke A; Mefferd CC; Villarama JV; Lai D; Consul A; Hedlund BP; Firestine SM; Abel-Santos E
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0143521. PubMed ID: 34780262
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.
McDonald JAK; Mullish BH; Pechlivanis A; Liu Z; Brignardello J; Kao D; Holmes E; Li JV; Clarke TB; Thursz MR; Marchesi JR
Gastroenterology; 2018 Nov; 155(5):1495-1507.e15. PubMed ID: 30025704
[TBL] [Abstract][Full Text] [Related]
19. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism.
Yu XH; Lv Z; Zhang CE; Gao Y; Li H; Ma XJ; Ma ZJ; Su JR; Huang LQ
J Ethnopharmacol; 2024 Feb; 320():117384. PubMed ID: 37925000
[TBL] [Abstract][Full Text] [Related]
20. Destination and Specific Impact of Different Bile Acids in the Intestinal Pathogen
Metzendorf NG; Lange LM; Lainer N; Schlüter R; Dittmann S; Paul LS; Troitzsch D; Sievers S
Front Microbiol; 2022; 13():814692. PubMed ID: 35401433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
